1. The aim of the study was to detect differences between salt-sensitive and salt-resistant hypertensive patients in the response of the renin-aldosterone axis, plasma noradrenaline and atrial natriuretic peptide to high salt intake. 2. Fifty essential hypertensive patients followed 2 weeks of a standard diet with 20mmol of NaCl daily, supplemented by placebo tablets for the first 7 days and by NaCl tablets for the last 7 days, in a singleblind fashion. Salt sensitivity was defined as a significant rise (P<O.O5) in 24h mean blood pressure obtained by ambulatory blood pressure monitoring from the low-to the high-salt period. Biochemical and hormonal measurements were performed on the last day of both periods. 3. Twenty-two (44%) patients fulfilled criteria of saltsensitive hypertension, whereas the remaining 28 (56%) were considered salt-resistant. High salt intake promoted a significant decrease (P< 0.05) in plasma creatinine, potassium, glucose, cholesterol, lowdensity lipoprotein-cholesterol, triacylglycerols, uric acid and plasma renin activity, and a significant increase in plasma atrial natriuretic peptide and 24 h urinary calcium excretion. The direction of these changes did not differ between salt-sensitive and saltresistant patients. Salt-resistant hypertensive patients exhibited a significant decrease in plasma aldosterone induced by high salt intake (from 446f35 to 226 f 35 pmol/l; P < 0.001), whereas this parameter was not significantly modified in salt-sensitive patients (from 485f76 to 364+83pmol/l; P not significant). Salt-sensitive patients showed an increase in plasma noradrenaline after high salt intake (from 1.15f0.11 to 1.56fO.l4nmol/l; P<O.O5), whereas salt-resistant patients presented a decrease in this parameter (from 1.48 f 0.08 to 1.12 f 0.08 nmol/l; P < 0.05). The change in plasma noradrenaline was directly correlated with the change in mean blood pressure induced by high salt intake (r = 0.479;
INTRODUCTION
Despite intensive research, the relationship between high salt intake and hypertension is still a matter of controversy [l] . The blood pressure response to NaCl in essential hypertensive patients is heterogeneous, at least during relatively short-term changes in salt intake [2] . Salt sensitivity, defined as a significant rise in blood pressure when individuals switch from a low to a high NaCl intake [3] is seen in a considerable number of patients with essential hypertension and, although less frequently, in normotensive subjects [4] .
The underlying mechanisms involved in the pathogenesis of salt sensitivity are not well established. Several mechanisms have been proposed to explain the blood pressure elevation in salt-sensitive individuals, such as an increase in sodium retention during high salt intake with a rightward shift of the pressure natriuresis curve [S-71, an increase in sympathetic nervous system activity [8-131, an enhanced blood vessel response to vasoconstrictor agonists [14] and an insufficient decrease in the renin-angiotensin-aldosterone axis during high salt intake [4, [8] [9] [10] .
On the other hand, it has recently been reported that sodium restriction may have some deleterious effects in several metabolic parameters, which may be potentially harmful in terms of cardiovascular risk [15-171. On the basis of these considerations, the aim of the present study was to detect differences between salt-sensitive and salt-resistant hypertensive patients in the response of the renin-aldosterone axis, plasma noradrenaline and atrial natriuretic peptide (ANP) to high salt intake.
PATIENTS A N D METHODS

Patient selection
Sixty-three essential hypertensive patients were originally recruited from the Hypertension Clinic of the Hospital Clinic, Barcelona, Spain. The diagnosis of essential hypertension was considered on the basis that no known cause of high blood pressure could be detected after complete clinical, biochemical and radiological examination. None of the patients had renal impairment, papilloedema, or evidence of cardiac failure, coronary or cerebrovascular diseases. All the patients had at least three ofice blood pressure measurements above 140/ 90mmHg after 4 weeks of an unrestricted salt diet and without antihypertensive medication. 'White coat' hypertension was ruled out by ambulatory blood pressure monitoring (ABPM) performed during the week previous to their inclusion in the study. Only 50 patients (23 males and 27 females) aged from 25 to 72 (mean+SEM 52.3f1.7) years whose mean 24 h diastolic blood pressure was above 90mmHg were included in the study. The remaining 13 patients presenting clinic blood pressure values over 140/90 mmHg, but with an average 24 h diastolic blood pressure below 90 mmHg were considered as having 'white coat' hypertension and were not included in the study.
Study protocol
The study was approved by the Ethics Committee of the University Hospital and by the Spanish Health Authority (Protocol F.I.S. 93/0177) and written informed consent was obtained from all participants. Essential hypertensive patients were admitted to a metabolic ward for the duration of the study. A low-salt diet containing 20mmol sodium daily was given to all participants for 14 days. The diet was prepared by the hospital dietary kitchen and contained 62g of protein, 2348 of carbohydrate, 108g of fat, 60mmol of potassium and 20mmol of calcium. The amount of calories remained constant for the whole study period and was slightly modified for individual needs. Patients were advised to drink 21 of water per day.
This baseline diet was supplemented in a singleblind fashion by placebo tablets during the first 7 days (low-salt period) and by NaCl tablets (240mmol daily) for the second 7 days (high-salt period). Consequently, the total NaCl intake during the high-salt period was 260 mmol daily.
Compliance with the diet was assessed by measuring the 24 h urinary Na' excretion daily throughout the study.
Laboratory measurements
Body weight, urine volume output, urinary Na', K + , Ca2+ and creatinine excretion were measured daily. A fasting blood venous sample was obtained on the last day of both low-and high-salt periods, with the patient in the recumbent position, and after 1 h of bed rest. Creatinine, glucose, cholesterol, LDL-cholesterol, high-density lipoprotein (HDL)-cholesterol, triacylglycerols, Na', K + , Ca2+, Mg2+ and uric acid determinations were obtained by means of a Technicon Dax-72 using standard laboratory methods. Creatinine clearance was obtained with the volume output, serum and urinary creatinine and corrected with respect to the body surface area. Plasma volume was measured by radioisotopic methods. Plasma renin activity (PRA), aldosterone, ANP and noradrenaline were measured using methods described previously [18] .
Blood pressure measurements
On the last day of both low-and high-salt periods, a 24h ABPM was carried out using an automated, non-invasive oscillometric device (SpaceLabs 90207; SpaceLabs Inc., Redmon, WA, U.S.A.). The appropriate cuff was placed on the nondominant arm, and blood pressure was registered automatically at 15 min intervals for a 24 h period, including waking or daytime period (from 08.00 to 23.00 hours), and sleeping or night-time period (from 23.00 to 08.00 hours). The following parameters were obtained from each record in the 24h period, as well as in day and night periods: mean values and SDs of systolic, mean and diastolic blood pressure and heart rate.
Definition of salt sensitivity
Unedited records obtained from ABPM carried out during either low-and high-salt periods were individually analysed by means of BMDP Statistical Software (BMDP, Berkeley, CA, U.S.A.). The normal distribution of 24 h blood pressure values for individual records was tested by the ShapiroFrancia test. If both records of the same subject were normally distributed they were compared by Student's t-test. If one or both records of the same subject were not normally distributed they were compared by the non-parametric Mann-Whitney test.
The blood pressure change in the whole group of essential hypertensive patients studied followed a Gaussian distribution, ranging from a decrease of 9 mmHg to an increase of 18 mmHg. There was not a clear cut-off in the blood pressure change which allowed us to define patients as having salt-sensitive or salt-resistant hypertension. Thus, the selection of I57 Table I . Mean values (f SEM) of blood pressure and heart rate in ult-sensitive and salt-resistant hypertensive patients during low and high ult intaker. a minimal increase in 24h blood pressure would have been completely arbitrary. In order to eliminate this arbitrariness, we chose the mathematical criterion of the statistical significance of the variation. Thus, salt sensitivity was diagnosed when the increase in 24 h mean blood pressure from the lowsalt period to the high-salt period was statistically significant (Pc0.05). It is important to note that all subjects classified as salt-sensitive presented an increase of at least 4mmHg in 24h mean blood pressure [19] .
Statistical analysis
Values are expressed as mean f SEM. The statistical method for the diagnosis of salt sensitivity is described above. Changes in the different parameters during low-and high-salt periods in saltsensitive and salt-resistant hypertensive groups were analysed by means of the two-way analysis of variance with the repeated measures design. Pairwise comparisons between salt-sensitive and saltresistant patients either at low or high salt intakes, as well as changes from low to high salt intake in the same group of patients, were performed using Student's t-test corrected with the Bonferroni method for four pairwise comparisons. The statistical analysis was performed with the aid of BMDP Statistical Package.
RESULTS
Blood pressure changes and salt-sensitive hypertension
Salt-sensitive hypertension was diagnosed in 22 patients (44%) using the aforementioned criteria. Their mean increase in 24h mean blood pressure was 6.5 f0.8 mmHg (from 109.7 & 2.5 mmHg at the end of the low-salt period to 116.2f2.6mmHg at the end of the high-salt period; P ~0.001). Conversely, 28 essential hypertensive patients (56%) were diagnosed as having salt-resistant hypertension. Their change in 24h mean blood pressure was -0.6 f 0.8 mmHg (from 110.2 & 2.3 mmHg to 109.6f 2.6 mmHg; P not significant). As shown in Table 1 , the change in both 24h systolic and diastolic blood pressure was only statistically significant in salt-sensitive patients. Twenty-four-hour heart rate decreased significantly with high salt intake, without differences between groups. High salt intake significantly reduced the nocturnal blood pressure fall (difference between daytime and nighttime blood pressures) in the whole group of patients (from 6.8 f 1.1 to 4.3f 1.1 mmHg; P=0.032). However, this was only significant in the salt-resistant group (from 9.2f1.3 to 5.1+1.3mmHg; P<0.05), not in the salt-sensitive group (from 3.8 f 1.6 to 3.3 f 2.0 mmHg; P not significant).
The baseline clinical characteristics of saltsensitive and salt-resistant hypertensive patients are shown in Table 2 . We did not find any significant difference in terms of age, gender, family history of hypertension, weight or body mass index.
Fluid and ionic changes
In all patients, high salt intake promoted a significant but clinically irrelevant decrease in plasma creatinine (from 74.4 f 2.59 to 69.7 + 2.55 pmol/l; P = 0.0067) and plasma potassium (from 3.99 f 0.06 to 3.79 f 0.08 mmol/l; P = 0.0100) and a significant increase in 24h urinary calcium excretion (from 3.91 f0.34 to 5.18f0.49 mmo1/24h; P = 0.01 11). No differences were observed with respect to the magnitude of these changes between salt-sensitive and salt-resistant patients (Table 3) .
Metabolic changes
As shown in Table 4 , body weight remained constant throughout the study. High salt intake seemed to exert a beneficial effect on most of the metabolic parameters. There was a significant decrease in plasma glucose (from 5.33k0.21 to 4.99 & 0.14 mmol/l; P = 0.0041), serum cholesterol P=0.0089) and uric acid (from 325k 13.9 to 256 f 11.6 pmol/l; P < 0.0001). There were no significant differences between salt-sensitive and saltresistant hypertensive patients, except for the change in LDL-cholesterol, which was statistically significant only in salt-resistant subjects (P < 0.05). Finally, high salt intake promoted a significant decrease in plasma Mg2
+ only in salt-sensitive patients (from 0.88 f 0.02 to 0.85 f 0.02 mmol/l; P -= 0.05).
Hormonal changes
High salt intake promoted a significant decrease in PRA (from 0.38f0.11 to 0.16+_0.03pmol of angiotensin I h-' ml-'; P=O.O439), without differences between salt-sensitive and salt-resistant patients (Table 5) . Likewise, plasma aldosterone significantly decreased in the whole group of hypertensive patients (from 463 & 38 to 286 f 41 pmol/l; P = 0.0004). The decrease in plasma aldosterone was statistically significant in the salt-resistant group (from 446 f 35 to 226 f 35 pmol/l; P <O.OOl), whereas salt-sensitive hypertensive patients did not modify these values (from 485 76 to 364 f. 83 pmol/ 1; P not significant). No difference in aldosterone was observed between salt-sensitive and saltresistant patients at either low or high salt intakes. A significant increase in ANP (from 15.2f 1.5 to 23.9 f 2.4 fmol/ml; P <0.0001) was observed in the whole group of hypertensives, as well as in both groups separately.
Plasma noradrenaline levels did not change for the group of essential hypertensive patients taken as a whole at the end of low-and high-salt periods (from 1.33k0.07 to 1.31 +0.08nrnol/l; P=0.7380). However, there was a clear difference in the direction of changes detected in each group. Saltsensitive patients presented an increase in plasma noradrenaline levels with high salt intake (from 1.15k0.11 to 1.56f0.14nmol/l; P<O.O5), whereas in salt-resistant patients these values decreased significantly (from 1.48+0.08 to 1.12k0.08; P<O.O5) (Fig.  1) . Values of plasma noradrenaline obtained at the end of low salt intake were not significantly different between salt-sensitive and salt-resistant patients ( 1.15 f 0.1 1 compared with 1.48 k 0.08 nmol/l; P not significant), whereas salt-sensitive patients presented significantly increased values at the end of the high-salt period (1.56 k0.14 compared with 1.12 f 0.08 nmol/l; P < 0.05). Finally, we observed a direct correlation between changes in 24 h mean blood pressure and changes in noradrenaline induced by high salt intake (r = 0.479; P = 0.003).
DISCUSSION
The present study shows the response of blood pressure, fluid, ionic, metabolic and hormonal parameters to changes in dietary salt intake in 50 essential hypertensive patients. Of these patients, 22 were classified as salt-sensitive. Salt sensitivity was defined as a significant rise (P<O.O5) in 24h mean blood pressure when subjects switched from a lowto a high-salt diet [19] . Changes induced by high salt intake comprised a significant decrease in plasma levels of creatinine, potassium, glucose, cholesterol, LDL-cholesterol, triacylglycerols, uric acid and PRA, and an increase in ANP and 24 h urinary calcium excretion. The direction of these changes did not differ between salt-sensitive and saltresistant subjects. Salt-resistant patients presented a significant decrease in plasma aldosterone with high salt intake, whereas salt-sensitive hypertensives did not modify these values. High salt intake promoted an opposite effect in plasma noradrenaline levels, with a reduction in salt-resistant patients and an increase in salt-sensitive hypertensive patients. The physiological consequences of salt loading or depletion have been extensively investigated in human hypertension. It has been reported that high salt intake promotes significant changes in volume and ionic homoeostasis, as well as in metabolic and hormonal parameters. Salt-sensitive individuals may differ from salt-resistant subjects in the extent or direction of these physiological changes.
Several studies have shown that high salt intake increases the renal excretion of calcium [20, 211 . It has been postulated that calcium deficiency may enhance smooth muscle cell contractility by an increase in intracellular calcium [21] . We have observed an enhanced renal excretion of calcium, but it was present in both salt-sensitive and saltresistant patients and we found no correlation with blood pressure changes.
From a metabolic point of view, high salt intake promoted significant decreases in several metabolic parameters, including plasma fasting glucose, cholesterol, LDL-cholesterol, triacylglycerols and uric acid. These results are in agreement with previous reports of increased serum cholesterol and LDLcholesterol, as well as C-peptide, after a low-salt diet [15-171. However, the validity of these results may be affected by several aspects concerning the design of the study. In this sense, it is important to note that the study was firstly designed to characterize essential hypertensive patients as salt-sensitive or salt-resistant using a different approach, based on a mathematical comparison of the records obtained by means of ABPM. There are some data in the literature (see Sullivan [3] for a review) indicating that the blood pressure response may not be equal when subjects switch from a low-to a high-salt diet compared with when subjects switch from a high-to a low-salt diet. Obtaining a homogeneous response in all the subjects analysed was the main reason for ordering the diets in the same sequence in all patients.
Several hormonal parameters have been corre-lated with salt sensitivity. Kawasaki et al. [7] showed a lower PRA and lower plasma aldosterone in salt-sensitive patients. Likewise, high salt intake promoted a decrease in both parameters. These results have also been confirmed by most authors [4, 5, 8, 11, 14, 16, [21] [22] [23] [24] [25] [26] [27] [28] . Low plasma renin appears to be a predictor of salt sensitivity, although its accuracy is poor. In a study by Weinberger et al. [4] , only 68% of patients with low plasma renin were diagnosed as salt-sensitive. In the present study, we did not find differences in PRA values between salt-sensitive and salt-resistant patients, either at low or high salt intakes, although it is important to note that PRA values exhibited high inter-individual variability. The response of PRA and aldosterone to different levels of salt intake has also been studied by several authors. Most of them found a blunted decrease of these hormonal parameters in salt-sensitive subjects induced by high salt intake [8, 10, 14, 16, 22, 25, 281 or a greater response to the adrenal inhibitor aminoglutethimide [29, 301 . Salt-resistant patients presented a significant decrease in plasma aldosterone with high salt intake, whereas salt-sensitive hypertensives did not modify these values. It has been suggested from experimental studies that a defect in ANP release in response to sodium load may be a characteristic of salt-sensitive hypertension. Jin et al. [31] found that sodium loading was followed by an increase in ANP release in Wistar-Kyoto rats but not in spontaneously hypertensive rats. Likewise, Niimura et al. [32] observed attenuated release of ANP caused by sodium loading in salt-sensitive essential hypertensive patients. Conversely, Overlack et al. [22] found a greater increase in ANP concentration at the end of high salt intake in salt-sensitive normotensive individuals. The present results show an increase in ANP at the end of the high-salt period in all hypertensives. However, no differences were found in the response of ANP to changes in salt diet between salt-sensitive and salt-resistant hypertensive patients, as other authors have reported previously [24, 331. The sympathetic nervous system clearly seems to be involved in salt sensitivity [S, lo]. Indirect evidence of this role are reports of increased cardiac output, forearm vascular resistance and total peripheral resistance in salt-sensitive individuals. Campese et al. [11] found that salt-sensitive patients showed an abnormal relation between urinary sodium excretion and plasma noradrenaline levels. Furthermore, Koolen and van Brummelen [ 121 found a stimulatory 'escape' of plasma noradrenaline after 2 weeks of a high-salt diet only in saltsensitive individuals. Several studies have confirmed these results, showing that salt-sensitive essential hypertensive patients present elevated basal values of plasma or urinary noradrenaline [4, 9, 141 , a stimulation or a lack of suppression after high salt intake [8, 11, 12, [34] [35] [36] or an increased responsiveness to the pressor effect of plasma noradrenaline [13, 231. Our results are in agreement with those reported previously. Plasma noradrenaline was stimulated in salt-sensitive hypertensive patients with a high-salt diet, while salt-resistant patients showed a significant decrease in this parameter after sodium loading. A clear linear relationship was observed between changes in blood pressure and plasma noradrenaline in the group of hypertensives studied.
In conclusion, the results of the present study show an association between aldosterone and the sympathetic nervous system and salt sensitivity in essential hypertension. Salt-resistant patients present a decrease in plasma noradrenaline in response to increases in salt intake. Conversely, salt-sensitive hypertensive patients show an increase in plasma noradrenaline in response to the same dietary manoeuvre. A direct relationship has been observed between changes in blood pressure and changes in plasma noradrenaline in the whole group of subjects studied. On the other hand, salt-resistant patients present a significant decrease in plasma aldosterone in response to the high-salt diet, whereas saltsensitive patients do not modify these values. Other hormonal, fluid and electrolyte changes are directly correlated with the level of salt intake, but both salt-sensitive and salt-resistant patients respond in the same way, with no correlation between changes in these parameters and changes in blood pressure. Finally, although we found potentially beneficial changes in plasma glucose and lipid metabolism on switching from a low-salt diet to a high-salt diet, we cannot exclude an order effect due to the design of the study.
